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Abstract 
Plants area source of many valuable secondary metabolites that find a broad 
field of applications, ranging from the agrochemical to the pharmaceutical 
industries. Establishing a suitable source for extraction of phytochemicals is, 
however, not always straightforward. In many instances the production by chemical 
synthesis is not economically viable due to their complex structures and 
conservation issues may arise when they are harvested from natural sources. In 
vitro culture techniques offer an attractive alternative to these issues. Natural grown 
plants can be replaced by in vitro produced biomass with the advantage that several 
strategies can be implemented to increase production yields, such as genotype 
selection, altering growth conditions and use of elicitors, so that the higher 
investment costs are justified. Also, because plant tissue cultures can be generated 
on a continuous year-round basis without seasonal constraints, they can guarantee 
reliable and predictable production levels, which is of great importance for efficient 
process down-stream. Plant tissue culture techniques offer the possibility of 
establishing cultures from leaves, stems, roots and meristems, meaning that 
metabolites produced in specific plant organs can also be prospected. The successful 
production of a large number of phytochemicals from micropropagated biomass has 
been reported, and it seems that only in a few cases cultures fail to accumulate 
compounds of interest. The advantages and the range of possibilities offered by 
plant tissue culture techniques suggest that these might become a valuable and 
indispensable tool for the production of phytochemicals. In this work, the example of 
the prospection of plumbagin from micropropagated D. intermedia plants is 
described. Plumbagin is a naphthoquinone with potential pharmaceutical 
applications and results obtained by several hyphenated analytical techniques 
confirm that an end product with high purity and recoveries can be obtained from 
in vitro cultured plants. 
 
INTRODUCTION 
 
The Importance of the Plant Kingdom 
Many specialty materials that find application in the pharmaceutical, food, 
cosmetic and agrochemical industries are obtained from plants. It is estimated that plant-
derived natural products represent more than 25% of all drugs in clinical use in the world 
(Rates, 2000; Gurib-Fakim, 2006). Examples of important drugs obtained from plants are 
digoxin from Digitalis spp., quinine and quinidine from Cinchona spp., vincristrine and 
vinblastine from Catharanthus roseus, atropine from Atropa belladonna and morphine 
and codeine from Papaver somniferum (Rates, 2000). However, the potential of higher 
plants as a source for new drugs is still largely unexplored. Among the estimated 250000-
500000 plant species, only a small percentage has been investigated chemically and the 
fraction submitted to biological or pharmacological screening is even smaller (Hamburger 
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and Hostettmann, 1991). In this context the progressive loss of biodiversity is alarming, 
as it is predicted that 25% of today’s flowering plant species will be lost by 2025 
(Houghton, 2001). Regarding the field of herbal medicine, plant derived extracts, teas or 
capsules, designated more generically as phytomedicines or botanical drugs, are widely 
used in many European countries and USA, where they are produced according to high 
standards and submitted to thorough clinical trials (Lubbe and Verpoorte, 2011). 
Examples of popular phytopharmaceuticals are Gingko biloba, Hypericum perforatum 
(St. John’s Wort) and Valeriana officinalis (Valerian) extracts (Houghton, 2001). It is 
difficult to assess the global turnover of plant derived fine chemicals on a yearly basis, 
but the figures concerning the exportation and importation of medicinal and aromatic 
plants alone amounted to considerable values (Table 1) in the period of 2004-2008. Also, 
many plant species are in demand for dye extraction due to an increasing popularity of 
natural dyes. Tagetes patula, Juglans regia, Lawsonia inermis are examples of plants 
from which dyes are obtained. Other species are sources of valuable materials for the 
manufacture of cosmetic products, such as oils, fats and waxes, essential oils and 
oleoresins and plant extracts. In the agrochemical sector, many insect, microbial 
pathogens and weed control agents are obtained from plants. Some examples are nicotine 
isolated from Nicotiana spp., karanjin from Derris indica and eugenol extracted from 
Eugenia caryophyllus (Lubbe and Verpoorte, 2011). 
 
Sources of Plant Material: from Wild Collection to In Vitro Production  
In the case of pharmaceutical and other large industries, cultivation is usually done 
under contract to ensure a reliable supply of material but also to allow higher 
standardization of raw materials. However, in most cases raw materials are harvested 
from nature due to lower investment requirements. When raw material is obtained from 
widely occurring, fast growing species whose foliage alone is harvested, over-harvesting 
does not have to be an issue. However, when dealing with slow-growing species with 
limited distribution and when obtaining the end product involves harvesting the roots or 
bark, over-harvesting and consequently conservation problems may arise (Lubbe and 
Verpoorte, 2011). As an alternative, the pharmaceutical industry has recurred to chemical 
synthesis to produce many plant-derived pharmaceuticals, which has largely been 
successful. However, in some cases this has proved to be uneconomic in comparison to 
isolation from plant material. Camptothecin (Camptotheca acuminata), podophyllotoxin 
(Podophyllum hexandrum), vinblastine and vincristine are examples of anticancer 
compounds that are extracted from their natural sources and not synthesized chemically 
on a commercial scale due to their complex structure with several chiral centres (Wink et 
al., 2005). Also, the fact that many plant species are not easy to cultivate and have 
specific climatic requirements, has as repercussion inconsistent production and low 
yields, making the approach of cultivation unfeasible in the long term (Georgiev et al., 
2009).  
In response to these issues, in vitro culture technology has become an attractive 
and cost-effective alternative for the production of high value plant-derived metabolites. 
Plant cell and tissue cultures can be established routinely under sterile conditions from 
explants, such as plant leaves, stems, roots and meristems for both multiplication and 
extraction of chemicals, as they produce and accumulate many of the same valuable 
compounds as the parent plant in nature. Secondary metabolite production in plant cell 
and tissue culture has the advantage of being reliable, predictable, generated on a 
continuous year-round basis without seasonal constraints, and in some cases yields may 
exceed the ones found in nature (Debnath et al., 2006; Karuppusamy et al., 2009). As an 
alternative, this technology can be used to produce plantlets at large scale for cultivation. 
For instance, the sexual reproduction of Gingko biloba is compromised by the recalcitrant 
nature of its seeds, which has encouraged many research projects towards the production 
of plantlets by means of in vitro culture techniques (Tommasi and Scaramuzzi, 2004; 
Uchendu et al., 2011). However, considering the high investment of in vitro culture in 
comparison to traditional cultivation, it is expected that these techniques will only be 
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employed for the production of phytochemicals with added value. 
In a limited number of instances production of high-value phytochemicals in 
non-organized callus and suspension cultures using bioreactors was successfully 
implemented. Paclitaxel is an alkaloid that was first isolated from the bark of Taxus 
brevifolia, during a screening program of the United States National Cancer Institute, and 
is currently produced by plant cell fermentation by Phyton Biotech (Germany). Sold 
under the trademark Taxol®, paclitaxel is used in cancer chemotherapy to treat lung, 
ovarian and breast cancer and is a good example of commercially viable production of 
secondary metabolites using biotechnological approaches (Wink et al., 2005). 
However, undifferentiated callus and suspension cultures very often fail to 
accumulate the compounds of interest. This situation occurs when the metabolite is only 
produced in specialized plant tissues or glands in the parent plant and production requires 
more differentiated microplant or organ cultures. A prime example is the production of 
ginseng saponins (Panax ginseng), for which root culture is required as these saponins are 
produced specifically in the roots (Karuppusamy, 2009). On the other hand, organized 
tissue cultures such as shoot and root cultures, as well as hairy roots, hardly ever fail to 
synthesize secondary metabolites. Karuppusamy (2009) presents an extensive review on 
the metabolites produced by in vitro tissue, organ and cell cultures, showing the potential 
of these techniques to produce the most diverse phytochemicals. 
 
CASE STUDY: PLUMBAGIN RECOVERY FROM DROSERA INTERMEDIA 
The following section describes the research effort developed at the Plant 
Biotechnology Laboratory (University of Algarve) to reach a chemically well-defined 
phytochemical from in vitro reared plants, ranging from the development of a 
micropropagation protocol, to the process development for the extraction and purification 
of plumbagin from D. intermedia. 
 
D. intermedia 
Drosera intermedia (H.) Hayne, or spoonleaf sundew, is a perennial herb that 
forms a semi-erect stemless rosette of spatulate leaves (Fig. 1A) and is typically found in 
nutrient-poor peat lands including rain-fed bogs and poor fens (Juniper et al., 1989). The 
genus Drosera (Droseraceae) comprises nearly 150 species with a worldwide 
distribution. However, the vast majority of species are found in the Southern Hemisphere, 
especially in south-western Australia (Rivadavia et al., 2003). In Europe only three 
species exist, Drosera anglica, D. intermedia and D. rotundifolia (Crowder et al., 1990). 
Plants of the Drosera genus bear leaves with pin-shaped tentacles covered at the tip with 
glistering drops of mucilage that resemble drops of morning dew and to which they owe 
their scientific name (from Greek droseros, dewy) and their common name of sundew 
(Crowder et al., 1990). Drosera species have long held the interest of botanists and 
horticulturists because of their unique biology and carnivorous habit. However, apart 
from their ornamental value, Drosera plants have medicinal significance and due to 
uncontrolled collection, natural populations are becoming increasingly scarce, especially 
in Europe where the Drosera species are included in the European Red List of Threatened 
Plants (Kawiak et al., 2003). D. intermedia produces self compatible flowers and is also 
able to reproduce vegetatively by production of side rosettes during the growing season, 
regeneration of plantlets on senescing tissue and formation of axillary buds in autumn (de 
Ridder and Dhondt, 1992). D. intermedia is known to produce plumbagin (Budzianowski, 
1996) but the biochemical description of this species in literature is poor. D. intermedia 
has been used as an infusion or a tincture for asthma, pulmonary catarrh and whooping 
cough (Crowder et al., 1990). 
 
The Naphthoquinone Plumbagin 
Plumbagin (5-hydroxy-2-methyl-1,4-naphthalenedione; Fig. 2) is the most 
efficient secondary metabolite isolated so far from carnivorous plants (Eilenberg et al., 
2005). This naphthoquinone has received an enormous amount of attention in 
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pharmacological research due to its antimalarial (Likhitwitayawuid et al., 1998), 
antimicrobial (Didry et al., 1994, 1998), antifungal (Ribeiro de Paiva et al., 2003), 
anticancer (Parimala and Sachdanandam, 1993; Sugie et al., 1998), antimutagenic (Durga 
et al., 1992), cardiotonic (Itoigawa et al., 1991), hypolipidemic and antiatherosclerotic 
effects (Sharma et al., 1991). Despite the broad range of biological activities of 
plumbagin, its high cytotoxicity and relative low therapeutic selectivity are the major 
disadvantages that limit its medical application (Kayser et al., 2003). To circumvent this 
problem several synthetic plumbagin derivatives have been examined to identify products 
exerting plumbagin-like activity and lower toxicity (Ogihara et al., 1997; Hazra et al., 
2002; Tandon et al., 2005). Nevertheless, it has been shown recently that at subtoxic 
concentrations, plumbagin is proving to be an effective agent against several 
pharmacological targets and has regained the interest of researchers in the field of drug 
discovery in the past years (Shieh et al., 2010; Luo et al., 2010) (Fig. 3). Furthermore, the 
inhibition of insect ecdysis and chitin synthetase by plumbagin suggests that plumbagin 
and its closely related derivatives may serve as environmentally friendly insect control 
agents and be of value to the agrochemical industry (Kubo et al., 1983). 
 
Occurrence and Biological Significance of Plumbagin 
Naphthoquinones are one of the groups of secondary metabolites widespread in 
nature. Plumbagin is produced by a disperse and heterogeneous group of plant families 
and can be found in members of the Droseraceae (Marckzack et al., 2005), 
Plumbaginaceae (Ribeiro de Paiva et al., 2003), Nepenthaceae (Rischer et al., 2002), 
Ebenaceae (Dzoyem et al., 2007) and also in Drosophyllum lusitanicum (Grevenstuk et 
al., 2008) and Triphyophyllum peltatum (Bringmann et al., 2000), which belong to the 
monotypic families Drosophyllaceae and Dioncophyllaceae, respectively. The production 
of naphthoquinones is common in carnivorous plants but not exclusive to this group of 
plants. The ability of naphthoquinone synthesis is not limited to higher plants. 
Naphthoquinones have also been found in fungal organisms in genera such as 
Aspergillus, Cladosporium, Fusarium, Microsporium, Mollisia, Penicillium, 
Trichophyton and Verticillium and Actinomycetes of the genus Streptomyces (Medentsev 
and Akimenko, 1998). Plumbagin, however, has not been found in these organisms to 
date. 
Besides the effects of plumbagin on pharmacological targets, there are many 
reports on its allelochemical effects on organisms of interest in the ecological context. 
Plumbagin acts as an antifeedant agent on herbivorous insects, including adapted 
Lepidoptera (Villavicencio and Perez-Escandon, 1994), is responsible for fungicidal 
activity against phytopathogenic species, acts as a potent phytoalexin against parasitic 
plants (Bringmann et al., 1999) and inhibits the germination of seeds from other species 
(Gonçalves et al., 2009). These findings support the importance of the production of 
plumbagin and related naphthoquinones, improving the plants’ fitness and conferring an 
adaptive advantage over other plants (Rischer et al., 2002). 
 
The Exploitation of Plumbagin 
At present, the most exploited source of plumbagin are the roots of Plumbago spp. 
However, these plants grow quite slowly and the roots suitable for extraction take years to 
grow (Komaraiah et al., 2003). Moreover, conventional propagation of the plant is rather 
difficult and insufficient to meet the growing demand, owing to the poor germination of 
seeds and death of young seedlings under natural conditions (Verma et al., 2002). 
Attempts to produce plumbagin synthetically proved to be commercially ineffective 
(Ichihara et al., 1980; Wurm and Gurka, 1986), and therefore alternatives for the 
production of plumbagin based on in vitro techniques should be sought. 
Nahálka et al. (1996) showed that cell suspension cultures of D. lusitanicum are 
capable of producing large quantities of plumbagin in a short amount of time. However, 
vitality of the suspension was relatively low because of cell plasmolysis and 
compromised the process viability (Nahálka et al., 1998). Plumbagin is produced mainly 
19 
in the roots of Plumbago spp., therefore, researchers used another approach using hairy 
root cultures in the expectation that it might lead to high levels of plumbagin production 
(Verma et al., 2002; Gangopadhyay et al., 2008). Hairy roots are obtained by 
transforming root cultures with Agrobacterium rhizogenes, resulting in a phenotype that 
is characterized by fast hormone-independent growth, lack of geotropism and genetic 
stability (Veena and Taylor, 2007). Despite achieving promising biomass production 
rates, the plumbagin content was too low for commercial exploitation. 
Komaraiah et al. (2003) used an improved method to produce plumbagin using 
Plumbago indica (same species as P. rosea) cell cultures. The cells were immobilized in 
calcium alginate while elicitated using chitosan and plumbagin was recovered 
simultaneously using in situ adsorption. Elicitors are signal compounds of plant defence 
responses, which can therefore enhance the production of secondary metabolites. The 
most frequently used elicitors are fungal carbohydrates, yeast extract and chitosan 
(Karuppusamy, 2009). The immobilized cell system enhanced plumbagin production, 
possibly due to increased degree of differentiation or cell-to-cell contact (Komaraiah et 
al., 2001). In situ direct extraction also increased plumbagin recoveries by reducing the 
toxic effects of plumbagin on the cells and feedback inhibition of secondary metabolite 
synthesis. However, Plumbago plants might not be the most adequate source of plant 
material for the bioprospection of plumbagin because its content in field specimens is 
lower when compared to other plumbagin bearing plants, such as D. lusitanicum for 
instance (Grevenstuk et al., 2008). Drosera spp. were never seriously considered for 
plumbagin prospection due to their low biosynthesis of this naphthoquinone (Crouch et 
al., 1990), nevertheless, this issue is controversial since higher recoveries have been 
obtained from Drosera plants in comparison to Plumbago plants (Marczak et al., 2005; 
Krolicka et al., 2008; Putalun et al., 2010). 
 
Bioprospection of Plumbagin from Micropropagated D. intermedia 
1. Micropropagation of D. intermedia and Evaluation of Biomass Production. A 
micropropagation protocol to produce D. intermedia biomass at large scale was 
developed in order to optimize the plumbagin extraction procedure (Grevenstuk et al., 
2010). In brief, initial explants were obtained from seedlings (Fig. 1B) germinated in ¼ 
Murashige and Skoog (1962; MS) medium under a 16-h photoperiod at a temperature of 
25  2ºC. Seedlings were sub-cultured onto media with three concentrations of MS 
macro-nutrients (total MS, ½MS and ¼MS) supplemented with 0.1 mg dm-3 of kinetin or 
without plant growth regulators and after 8 weeks of culture proliferation and rooting 
parameters were evaluated. The results showed that proliferation was not affected by 
addition of kinetin but was significantly influenced by MS macronutrient concentration. 
The highest proliferation was obtained in ¼MS medium, which is in agreement with 
results obtained for other carnivorous plants and seems to be a characteristic to this group 
(Jang et al., 2003; Kim and Jang, 2004; Gonçalves et al., 2005). The rooting capacity of 
shoots was barely influenced by the variables introduced in the experiment as rooting 
percentages of 100% were obtained in nearly all cases. Either way, this parameter is of 
less importance since the main purpose of the protocol is to obtain high biomass 
production levels. Therefore, the proliferation rate is preponderant in this case and the 
best medium to produce D. intermedia biomass was found to be ¼MS medium without 
plant growth regulators (Fig. 1C). 
To determine the optimum harvesting period, the biomass increment of D. 
intermedia cultures was monitored over time. The culture growth index was calculated as 
the fresh weight gain divided by the culture’s initial fresh weight and was registered at 2 
week intervals during 16 weeks of culture. Separate cultures with the same culture time as 
the ones used for plumbagin extraction were dried until constant weight to determine its 
water content for dry weight yield determination. The growth curve obtained for D. 
intermedia cultures (Fig. 4) shows that the biomass increases slowly during the first 6 
weeks of culture, period after which the cultures grow more vigorously, reaching a 9.70 ± 
0.94 fold increase in biomass after 10 weeks of culture. The efficiency of in vitro culture 
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methods is usually evaluated in terms of the capacity of an explant to generate new 
shoots, instead of biomass production. It is therefore difficult to assess the efficiency of 
D. intermedia biomass production in the tested growth conditions, as these results are 
available only for few Drosera species. However, D. intermedia does seem to grow more 
vigorously than Drosera capensis. After 4 weeks of growth in ½MS medium, biomass 
gain of D. capensis control cultures amounted to 1.193 ± 0.035 g FW/g initial FW 
(Krolicka et al., 2008), while for D. intermedia a gain of 2.79 ± 0.10 g FW/g initial FW 
(result not shown; 1.74 ± 0.10 fold biomass increment) was scored. The same author also 
reported a two-fold increase in biomass production after addition of jasmonic acid, 
meaning that the biomass production of D. intermedia could be further enhanced. 
The biosynthesis of plumbagin was not monitored over time, which could lead to 
misassumptions concerning the optimum harvesting time, as the production of plumbagin 
can vary depending on the growth phase. However, Verma et al. (2002) showed that the 
highest plumbagin concentration found in the roots of P. zeylanica hairy cultures 
coincided with the period with the highest biomass production. The authors reported a 21 
fold increase in biomass yield after 6 weeks of culture. The higher biomass production 
yields reported for P. zeylanica cultures are expectable since hairy roots have higher 
growth rates and no growth regulators were used when producing D. intermedia cultures. 
2. Optimization of Plumbagin Extraction. To evaluate the plumbagin bioproduction 
levels of D. intermedia, several extraction techniques were employed, including 
maceration under mechanical stirring, Soxhlet extraction (SE), Ultrasound Assisted 
Extraction (UAE) and Supercritical Fluid Extraction (SFE). Solvent extractions were 
performed with n-hexane using the same volume of solvent to compare extraction 
efficiency and supercritical CO2 without modifiers was the solvent of choice for SFE. The 
results were recently published (Grevenstuk et al., 2012) and indicated that the amount of 
plumbagin that can be recovered from D. intermedia is considerable. Table 2 summarizes 
the obtained recoveries and shows that as much as 3.12 ± 0.05 mg/g FW can be obtained 
when using UAE.  
Although all extractions were performed with fresh plant material, the content in 
plumbagin is presented on fresh weight and dry weight basis in order to allow comparison 
with previous publications. Despite the fact that most extraction methods use dry plant 
material, for the purpose of this work the extractions were performed with fresh plant 
material because the extraction of plumbagin is greatly hampered when using dry material 
(Verma et al., 2002; Marczak et al., 2005; Grevenstuk et al., 2008). Marczak (2005) 
hypothesized that plumbagin may be more strongly bound to the dry plant matrix instead 
of being decomposed during the drying process. The author showed that it was possible to 
extract plumbagin from dried material with methanol, even after it had been extracted 
with chloroform, possibly due to easier disruption of intermolecular interactions with the 
more polar solvent. When performing extractions with fresh samples, higher yields were 
obtained with chloroform than with the other solvents. 
3. D. intermedia as a Source of Plumbagin. As mentioned earlier, plumbagin is 
currently exploited from plants of the Plumbago genus. However, when comparing the 
recoveries presented in Table 2 with the contents in plumbagin of Plumbago spp. reported 
in literature, one can conclude that D. intermedia could be an alternative source of 
plumbagin. The content in plumbagin obtained by maceration with ethyl acetate of dried 
P. zeylanica roots varies between 0.629 and 4.975 mg/g according to Wang et al. (2005). 
For the same species, Hsieh (2005) reported a recovery of 13.40 ± 1.30 mg/g DW after 
extracting the plant material with boiling ethanol. Another author reported recoveries of 
1.50, 1.91 and 1.40 mg/g DW obtained from roots of Plumbago auriculata, P. indica and 
P. zeylanica, respectively, obtained by SE with acetone (Mallavadhani et al., 2002). 
Despite the fact that in these reports the plant material was dried prior to extraction and 
the extraction procedures are diversified, the recoveries are in some cases considerably 
lower than those obtained from D. intermedia. The lowest plumbagin recovery was 17.51 
± 1.40 mg/g DW, obtained by maceration. Roots of P. scandens were extracted by SFE 
with plumbagin contents ranging from 0.056 to 1.93 mg/g FW depending on the time 
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period between collection and extraction (Rodrigues et al., 2006). Using the same 
extraction method and experimental conditions, 2.54 ± 0.14 mg/g FW were obtained from 
D. intermedia. It is worth underlining that the results mentioned above were obtained 
from field specimens of Plumbago spp. and might therefore be overestimated. The 
differences of the recoveries reported in literature for plants of the Plumbago genus, even 
for those of the same species, are in part due to the different extraction procedures but 
also due to geographical and seasonal factors which affect the content in secondary 
metabolites, underlining one of the advantages of using in vitro cultures for 
bioprospection, as it is a more reliable and qualitatively consistent source of plant 
material. In fact, by comparing the presented experimental deviations obtained in a 
similar study conducted with field specimens of D. lusitanicum (Grevenstuk et al., 2008) 
one can conclude that issues of material homogeneity are greatly reduced when using 
micropropagated plant material. 
 Several biotechnological approaches have been used to improve the production 
yield of plumbagin of Plumbago spp., while simultaneously preventing harvesting of the 
whole plant. Hairy root cultures have been established from P. zeylanica (Verma et al., 
2002) and P. indica (Gangopadhyay et al., 2008) with the intent of increasing the growth 
rate and plumbagin production. The hairy root cultures resulted in increased plumbagin 
yields in comparison to untransformed roots (8.40 mg/g DW from P. zeylanica; 6.18 
mg/g DW from P. indica), however, the obtained plumbagin contents are inferior to those 
obtained from D. intermedia cultures (Table 2). Another approach used to improve the 
production of plumbagin was to immobilize cell cultures of P. indica in calcium alginate 
while being elicited with chitosan and collecting plumbagin by in situ adsorption, thereby 
reducing the feedback inhibition of secondary metabolite production (Komaraiah et al., 
2003). This way, recoveries of 92.13 mg/g of dry cell weight (DCW) were obtained, 
which is nearly four times more than the highest recovery obtained from D. intermedia 
(24.78 ± 0.55 mg/g DW). In the cited study, the step of plumbagin elicitation with 
chitosan alone was responsible for a production increment of over six times, meaning that 
the production of plumbagin by D. intermedia could be enhanced considerably as well 
using adequate elicitors. In a different study the production of plumbagin by Drosera 
burmanii suffered a 3.5-fold increase over control due to elicitation by yeast extract 
application (Putalun et al., 2010). 
D. intermedia produces significant amounts of plumbagin, even when compared to 
plants of the same genus. D. intermedia seems to produce higher levels of the 
naphthoquinone then the eight in vitro cultured Drosera species evaluated by Marczak 
(2005). In this study, the highest plumbagin recovery was obtained from D. binata (12.4 
mg/g DW) using UAE with chloroform as extracting solvent. Using the same extraction 
technique, higher recoveries were obtained from D. intermedia (24.78 ± 0.55 mg/g DW). 
It has to be stated that chloroform can give higher recoveries, although this increment 
usually comes at cost of the extract purity, because a greater amount of undesired 
compounds are co-extracted (Grevenstuk et al., 2008). 
The plumbagin production levels of D. intermedia seem to be similar to those 
reported for D. lusitanicum (Grevenstuk et al., 2008). Field specimens were extracted 
with n-hexane using SE and UAE affording recoveries of 2.42 ± 0.39 mg/g FW and 1.52 
± 0.39 mg/g FW, respectively. The recovery of plumbagin using SE is comparable to the 
one obtained from D. intermedia (2.67 ± 0.04 mg/g FW). The plumbagin content of the 
extract obtained by UAE is lower compared to the one obtained from D. intermedia (3.12 
± 0.05 mg/g FW), but this can be explained by the fact that an experimental setup with a 
horn transducer was used to deliver ultrasounds to the D. lusitanicum matrix, instead of 
an ultrasound bath. In this setup, the ultrasounds are only delivered efficiently to the plant 
matrix close the horn transducer, leading to lower recoveries. In a different work, cell 
suspension cultures were established from D. lusitanicum, yielding high amounts of 
plumbagin (35 mg/g Fresh Cell Weight) (Nahálka et al., 1996). The cell suspension 
culture was able to produce over 10 times more than the mother plant, but the cultures 
underwent a strong plasmolysis short after being transferred to the liquid medium, 
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making this approach unviable. D. lusitanicum is a species endemic to the Iberian 
Peninsula and northern Morocco and is in risk of eminent extinction; therefore harvesting 
this plant from the wild for plumbagin extraction is unfeasible and irresponsible from an 
ecological perspective. An in vitro culture protocol has been developed for D. lusitanicum 
(Gonçalves et al., 2005), but D. intermedia seems to grow easier and more vigorously in 
these conditions. 
4. Plumbagin Identification and Purity Determination. In order to confirm that 
plumbagin was in fact being extracted, a sample was cleaned using a solid phase 
extraction (SPE) column and analysed by Mass Spectrometry and Nuclear Magnetic 
Resonance experiments (NMR). The negative-ion ESI-MS spectrum showed only one 
major peak with a pseudo-molecular ion peak [M-H]- at m/z (mass to charge ratio) 187, 
suggesting a molecular formula of C11H8O3. Because the extract was very concentrated, a 
good quality Heteronuclear Multiple Bond Correlation (HMBC) spectrum was obtained 
and by comparison with literature data the main compound of the extract could readily be 
identified as plumbagin (Sankaram et al., 1986). The obtained 13C and 1H NMR spectra 
pointed out a lack of signals belonging to contaminating compounds, indicating that the 
analysed sample is practically pure. Subsequently, the samples obtained by different 
extraction methods were cleaned with the same SPE procedure as well and analysed by 
HPLC for purity determination. The obtained results were remarkable as in some cases 
purities over 99.5% were achieved (Table 3). The products obtained from the SE and 
UAE extracts were the most pure (P < 0.05), with purities of 99.91 ± 0.09% and 99.51 ± 
0.49%, respectively. Another positive result was that the product recovery of the process 
was relatively high (86.31% for extract obtained by SFE) meaning that 2.74 mg of 
plumbagin (> 99% purity) can be obtained from 1 g of micropropagated plant material 
(Grevenstuk et al., 2012).  
 
CONCLUSIONS 
The presented results show that high purity plumbagin can be produced 
sustainably from D. intermedia cultures with high yields. These results are an example of 
an application of in vitro culture techniques for the production of fine chemicals. 
D. intermedia cultures grow fast and have high levels of plumbagin bioproduction and 
could therefore represent an alternative for the bioprospection of plumbagin. Taking into 
consideration that no growth regulators or elicitors were used it is possible that the 
production of plumbagin can be further enhanced. Furthermore, extracting plant 
metabolites from in vitro cultures is desirable when high yields can be obtained, because 
plant materials are not completely homogeneous and are affected by seasonal and 
geographical factors. Micropropagated plant material is more reliable and homogeneous 
and this might enable the scale-up of an efficient process amenable to industry. 
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Tables 
 
Table 1. The top twelve medicinal and aromatic plants importing and exporting countries, 
listed according to descending order of average trade volumes between 2004 and 2008 
(Adapted from Lubbe and Verpoorte, 2011). 
 
2004-2008 Imports  2004-2008 Exports 
Country Tonnes Value (US$)a  Country Tonnes Value (US$)a 
USA  62038 220638 China 204082 348821 
Hong Kong 48168 167298 India 47551 93450 
Germany  47814 139684 Mexico 38262 38081 
Rep. Koreab  34732 47563 Egypt 24600 34151 
Japan 27937 118514 Germany 18076 99349 
China  27754 34808 Polandb 15775 47183 
France 20336 72471 Hong Kong 15011 81698 
UK  17895 51006 USA 13919 95704 
Spainb  15670 44337 Chileb 11627 27656 
Italy 13436 59582 Moroccob 10796 19463 
Malaysia 11348 44058 Bulgaria 9338 21088 
Pakistan  11045 4733 Albania 7770 17084 
a In thousands of US dollars. 
b Average from 2004 to 2007; data from 2008 not available. 
 
Table 2. Extraction parameters of plumbagin from D. intermedia using different 
extraction methods (Grevenstuk et al., 2012). 
 
Method Extraction yield Plumbagin content 
 (mg extract/g FW) (mg/g FW) (mg/g DW)
* 
Maceration 5.23 ± 0.61 a 2.21 ± 0.17 c 17.51 ± 1.40 c 
SE 5.63 ± 0.14 a 2.67 ± 0.04 b 21.18 ± 0.44 b 
UAE 5.14 ± 0.54 a 3.12 ± 0.05 a 24.78 ± 0.55 a 
SFE 5.93 ± 0.44 a 2.54 ± 0.14 bc 20.15 ± 1.13 bc 
Values represent mean ± standard error of 3 repetitions. For each parameter values with different letters are 
significantly different at P < 0.05 according to Duncan’s multiple range test. *FW:DW ratio of 
D. intermedia cultures = 7.9 ± 0.13 : 1. 
 
Table 3. Purification of plumbagin from D. intermedia extracts using SPE (Grevenstuk et 
al., 2012). 
 
Method SPE yield (mg product/mg extract) Purity (%) SPE recovery (%) 
Maceration 0.37 ± 0.03 b 94.30 ± 1.80 b 82.58 ± 2.31 a 
SE 0.37 ± 0.01 b 99.91 ± 0.09 a 78.49 ± 2.13 a 
UAE 0.54 ± 0.06 a 99.51 ± 0.49 a 86.31 ± 2.40 a 
SFE 0.32 ± 0.04 b 83.90 ± 3.23 c 71.58 ± 3.44 b 
Values represent mean ± standard error of 3 repetitions. For each parameter values with different letters are 
significantly different at P < 0.05 according to Duncan’s multiple range test. 
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Figures 
 
 
 
 
Fig. 1. Micropropagation of D. intermedia: A – field specimen, B – seedling explant, C – 
shoots produced in ¼MS after 8 weeks of culture. 
 
 
 
 
Fig. 2. Structure of plumbagin. 
 
 
 
 
 
Fig. 3. Citation number in the period of 2000-2010 of published items with the following 
search criteria: topic=“plumbagin”, areas=“pharmacology and pharmacy”. 
Citation report generated by Web of Science (ISI Web of Knowledge). 
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Fig. 4. Growth index of D. intermedia cultures during a 16 weeks culture period. The 
culture growth index was calculated as the fresh weight gain divided by the 
culture’s initial fresh weight and was registered at 2 week intervals. 
